Our department for coronary heart diseases at Skåne University Hospital is the largest in Sweden for coronary angiography and percutaneous coronary intervention
 (PCI). Our outcome rates are equal to the best international centres, despite our numbers of high-risk patients and patients previously denied surgery. The department performs:

  • More than 3,500 coronary angiography and PCI procedures per year.
  • About 60 transcatheter aortic valve replacement (TAVR) procedures per year.

The department was the 9th centre in the world to acquire the Lotus Valve System, which is a novel TAVR valve with unique repositionable/retrievable properties. The Lotus Valve is used as primary valve, and due to the extensive experience in Lund the department takes part in the development of the national guidelines issued by the National Board of Health and Welfare.

The department has international collaboration with a large number of the worlds leading researchers in clinical cardiology and are leading several international studies. Further, the department has a network of all the major universities in Scandinavia with strong collaboration in clinical science. The department has published extensively in prominent medical journals over the last years (JACC, JAMA, ATVB, Science, Nature Medicine, Circulation, Circulation Research etc) including three papers in the New England Journal of Medicine.

Another example of the advanced methodology applied within our services is for patients with chronic symptomatic coronary artery disease, or refractory angina. The Central hospital in Kristianstad, in collaboration with Skåne University Hospital, was the first in Sweden with the non-invasive method of enhanced external counterpulsation therapy.